Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment efficacy and survival analysis
| Duration of Prior Sorafenib Treatment (months) | |
| Median (range) | 2.76 (2.12–6.18) |
| Number of B + E Treatment Cycles | |
| 1 | 0 (0 %) |
| 2 | 2 (20 %) |
| 3 | 8 (80 %) |
| Overall Survival (months) | |
| Median (95 % C.I.) | 4.37 (1.08, 11.66) |
| Progression-free Survival (months) | |
| Median (95 % C.I.) | 1.51 (1.08, 1.74) |
